Patents by Inventor Claude Bonde

Claude Bonde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20230364241
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: December 9, 2022
    Publication date: November 16, 2023
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20200316204
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 8, 2020
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Propylene Glycol-Containing Peptide Formulations which are Optimal for Production and for Use in Injection Devices
    Publication number: 20190231876
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 29, 2019
    Publication date: August 1, 2019
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Stable formulations of peptides
    Patent number: 8748376
    Abstract: Stable pharmaceutical composition comprising insulinotropic peptide.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: June 10, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Svend Ludvigsen, Morten Schlein, Tine Elisabeth Gottschalk Bøving, Claude Bonde, Anne-Mette Lilleøre, Dorthe Kot Engelund, Bjarne Rønfeldt Nielsen
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20120225810
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 31, 2012
    Publication date: September 6, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Patent number: 8158583
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: April 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Bøving, Morten Schlein
  • Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
    Patent number: 8114833
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: February 14, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Stable Formulations of Peptides
    Publication number: 20100173844
    Abstract: Stable pharmaceutical composition comprising insulinotropic peptide.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 8, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Svend Ludvigsen, Morten Schlein, Tine Elisabeth Gottschalk Boving, Claude Bonde, Anne-Mette Lilleore, Dorthe Kot Engelund, Bjarne Ronfeldt Nielsen
  • Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia
    Publication number: 20090286716
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 19, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Boving, Morten Schlein
  • Stable pharmaceutical compositions
    Patent number: 7595293
    Abstract: Pharmaceutical composition for parenteral administration comprising a glucagon-like peptide and human serum albumin or a variant thereof.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: September 29, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Dorthe Kot Engelund, Tina Bjeldskov Pedersen, Claude Bonde
  • Stable Formulations Of Peptides
    Publication number: 20080125361
    Abstract: Stable pharmaceutical composition comprising insulinotropic peptide.
    Type: Application
    Filed: November 14, 2005
    Publication date: May 29, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Svend Ludvigsen, Morten Schein, Tine Elisabeth Gottschalk Boving, Claude Bonde, Anne-Mette Lilleore, Dorthe Kot Engelund, Bjarne Ronfeldt Nielsen
  • Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
    Publication number: 20070010424
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: May 17, 2006
    Publication date: January 11, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Tina Pedersen, Claude Bonde, Dorthe Engelund
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Publication number: 20060287221
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 3, 2006
    Publication date: December 21, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Knudsen, Kristian Hansen, Dorthe Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Boving, Morten Schlein
  • Stable pharmaceutical compositions
    Publication number: 20060084605
    Abstract: Pharmaceutical composition for parenteral administration comprising a glucagon-like peptide and human serum albumin or a variant thereof.
    Type: Application
    Filed: October 3, 2005
    Publication date: April 20, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Dorthe Engelund, Tine Pedersen, Claude Bonde